Business · 11/07/2008Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Information Collection for Strategic National Stockpile Products
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on exceptions or alternatives to labeling requirements for products held by the Strategic National Stockpile, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →